Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension

被引:6
|
作者
Georges, Coralie M. G. [1 ]
Ritscher, Sabrina [2 ]
Pappaccogli, Marco [3 ]
Petit, Geraldine [4 ,5 ]
Lopez-Sublet, Marilucy [1 ,6 ]
Bapolisi, Achille [4 ,5 ,7 ,8 ]
Di Monaco, Silvia [3 ]
Wallemacq, Pierre [9 ,10 ]
Rabbia, Franco [3 ]
Toennes, Stefan W. [2 ]
de Timary, Philippe [4 ,5 ]
Persu, Alexandre [1 ,11 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiol, Brussels, Belgium
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany
[3] AOU Citta Salute & Sci, Dept Med Sci, Internal Med & Hypertens Div, Turin, Italy
[4] Catholic Univ Louvain, Clin Univ St Luc, Adult Psychiat Dept, Brussels, Belgium
[5] Catholic Univ Louvain, Clin Univ St Luc, Inst Neurosci, Brussels, Belgium
[6] CHU Avicenne AP HP, ESH Hypertens Excellence Ctr, Dept Internal Med, Bobigny, France
[7] Univ Catholique Bukavu, Bukavu, DEM REP CONGO
[8] Hop Prov Gen Bukavu, Bukavu, DEM REP CONGO
[9] Clin Univ St Luc, Clin Chem Dept, Brussels, Belgium
[10] Catholic Univ Louvain, Ctr Toxicol & Appl Pharmacol, Brussels, Belgium
[11] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, Brussels, Belgium
关键词
Resistant hypertension; drug adherence; psychological profile; expression of emotions; somatisation; EMOTION REGULATION; SOMATIZATION; ALEXITHYMIA; VALIDATION; MEDICATION;
D O I
10.1080/08037051.2022.2099346
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose In a pilot study including 35 patients with apparently treatment-resistant hypertension (ATRH), we documented associations between psychological profile, drug adherence and severity of hypertension. The current study aims to confirm and expand our findings in a larger and more representative sample of patients with ATRH, using controlled hypertensive patients as the comparator. Materials and Methods Patients with ATRH were enrolled in hypertension centres from Brussels and Torino. The psychological profile was assessed using five validated questionnaires. Drug adherence was assessed by high-performance liquid chromatography-tandem mass spectrometry analysis of urine samples, and drug resistance by 24-hour ambulatory blood pressure was adjusted for drug adherence. Results The study sample totalised 144 patients, including 81 ATRH and 63 controlled hypertensive patients. The mean adherence level was significantly lower in the "resistant" group (78.9% versus 92.7% in controlled patients, p-value = .022). In patients with ATRH, independent predictors of poor drug adherence were somatisation, smoking and low acceptance level of difficult situations, accounting for 41% of the variability in drug adherence. Independent predictors of severity of hypertension were somatisation, smoking, more frequent admissions to the emergency department and low acceptation, accounting for 63% of the variability in the severity of hypertension. In contrast, in patients with controlled hypertension, the single predictors of either drug adherence or severity of hypertension were the number of years of hypertension and, for the severity of hypertension, alcohol consumption, accounting for only 15-20% of the variability. Conclusion Psychological factors, mostly related to somatisation and expression of emotions are strong, independent predictors of both drug adherence and severity of hypertension in ATRH but not in controlled hypertensive patients. Plain language summary This study included 144 patients with Apparently-Treatment Resistant (ATRH) or controlled Hypertension: Patients with ATRH were more often poorly adherent to antihypertensive treatment than controlled hypertensive patients. In patients with ARTH but not patients with controlled hypertension, psychological traits were strong, independent predictors of drug adherence and severity of hypertension, over and above demographic and health-related factors. In patients with ATRH, the tendency to somatize, i.e. expressing somatic symptoms that cannot be adequately explained by organic findings was the most potent predictor of both poor drug adherence and severity of hypertension. These patients also often presented alterations in the expression of emotions. It may be hypothesised that subjects who have difficulties identifying and expressing emotions with words will express them by physical complaints, and, in the mid-long term, might develop overt diseases. In addition to more classical lifestyle and drug management and irrespective of their drug adherence level, patients with ATRH may benefit in priority from psychological evaluation and interventions. However, this needs to be studied in an interventional trial in the future.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 50 条
  • [31] DETERMINANTS OF CONTROLLED HYPERTENSION & PATIENT ADHERENCE TO HYPERTENSION TREATMENT IN INDONESIAN ADULTS: A MULTI-CENTER STUDY
    Nur, Aqsha A.
    Yuriza, Rizky E. P.
    Wicaksana, Bramantya
    Destini, Mulia
    Kusumanti, Bernita
    Monica, Charity
    Ramadhani, Rani
    JOURNAL OF HYPERTENSION, 2019, 37 : E1 - E1
  • [32] Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
    Glicklich, Daniel
    Frishman, William H.
    DRUGS, 2015, 75 (05) : 473 - 485
  • [33] Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
    Daniel Glicklich
    William H. Frishman
    Drugs, 2015, 75 : 473 - 485
  • [34] Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease
    Bangalore, Sripal
    Fayyad, Rana
    Laskey, Rachel
    DeMicco, David A.
    Deedwania, Prakash
    Kostis, John B.
    Messerli, Franz H.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (01): : 71 - +
  • [35] Prognosis of patients with apparent treatment-resistant hypertension-a feasibility study
    Hayes P.
    Kielty H.
    Casey M.
    Glynn L.G.
    Molloy G.J.
    Durand H.
    Newell J.
    Murphy A.W.
    Pilot and Feasibility Studies, 4 (1)
  • [36] Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension
    Ramik, Zdenek
    Vaclavik, Jan
    Kvapil, Tomas
    Jelinek, Libor
    Kocianova, Eva
    Kamasova, Monika
    Benesova, Klara
    Jarkovsky, Jiri
    Drapela, Martin
    Lys, Zdenek
    BLOOD PRESSURE, 2024, 33 (01)
  • [37] A study of Factors AssoCiated with Treatment Resistant HYpertension (FACT-RHY): description of phenotypical and biochemical characteristics of patients with true treatment-resistant hypertension compared to treated patients with hypertension
    Hameed, Mohammed
    Horton, Lesley
    Haque, Sayeed
    Gill, Paramjit
    Dasgupta, Indranil
    JOURNAL OF HUMAN HYPERTENSION, 2019, 33 : 18 - 19
  • [38] Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study
    Carcel, Cheryl
    Neal, Bruce
    Oparil, Suzanne
    Rogers, Kris
    Narkiewicz, Krzysztof
    Wang, Ji Guang
    Schiffrin, Ernesto L.
    Poulter, Neil
    Azizi, Michel
    Chalmers, John
    JOURNAL OF HYPERTENSION, 2019, 37 (11) : 2216 - 2224
  • [39] Assessment of fluid excess and body composition using bioimpedance spectroscopy in patients with adherence-proven treatment-resistant hypertension
    Hameed, Mohammed
    Haque, Sayeed
    Gill, Paramjit
    Dasgupta, Indranil
    JOURNAL OF HUMAN HYPERTENSION, 2019, 33 : 19 - 20
  • [40] Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension
    Elmula, Fadl M. Fadl Elmula
    Jin, Yu
    Yang, Wen-Yi
    Thijs, Lutgarde
    Lu, Yi-Chao
    Larstorp, Anne C.
    Persu, Alexandre
    Sapoval, Marc
    Rosa, Jan
    Widimsky, Petr
    Jacobs, Lotte
    Renkin, Jean
    Petrak, Ondrej
    Chatellier, Gilles
    Shimada, Kazuyuki
    Widimsky, Jiri
    Kario, Kazuomi
    Azizi, Michel
    Kjeldsen, Sverre E.
    Staessen, Jan A.
    BLOOD PRESSURE, 2015, 24 (05) : 263 - 274